NCT01086904View on ClinicalTrials.gov

Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

May 31, 2010

Conditions
Renal Transplant RecipientsImmunosuppression
Interventions
BIOLOGICAL

inactivated non adjuvanted pandemic H1N1 vaccine

two administrations at D and D21 (15 µg HA)

Trial Locations (3)

69437

Hôpital E. Herriot , Service de néphrologie, transplantation et immunologie clinique, Lyon

69495

Centre hospitalier Lyon Sud, service de néphrologie transplantation, Pierre-Bénite

75013

Service d'urologie, GH Pitié Salpêtrière, Paris

Sponsors

Collaborators (1)

MCM Vaccines B.V.
All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01086904 - Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients | Biotech Hunter | Biotech Hunter